DMRA
Damora Therapeutics, Inc.
-0.06 (-0.24%)24.47USD168K成交股數1.5B市值3.3本益比(近四季)184.9股價營收比+8018.0%營收年增(近四季)2026-11-05下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 1 · 7K · 1 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 7K |
| 近 180 天 淨額 | −7K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-06 | 07-07 | Winslow Garrett | General Counsel | S 公開市場賣出 | 245 | 29.98 | 7K | 2.3K | SEC |
| 2026-07-03 | 07-07 | Winslow Garrett | General Counsel | M 選擇權執行 | 680 | – | – | 2.5K | SEC |
| 2026-03-30 | 04-01 | Jarrett Jennifer | See Remarks | A 獲配股票 | 500K | – | – | 500K | SEC |
| 2026-02-09 | 02-12 | Fairmount Funds Management LLC | Director,TenPercentOwner | M 選擇權執行 | 5.8M | – | – | 5.8M | SEC |
| 2026-02-09 | 02-12 | Harwin Peter Evan | Director,TenPercentOwner | M 選擇權執行 | 5.8M | – | – | 5.8M | SEC |
| 2026-02-09 | 02-12 | Fairmount Healthcare Fund II L.P. | TenPercentOwner | M 選擇權執行 | 5.8M | – | – | 5.8M | SEC |
| 2026-02-09 | 02-12 | Kiselak Tomas | TenPercentOwner | M 選擇權執行 | 2.9M | – | – | 2.9M | SEC |
| 2026-02-09 | 02-12 | Harwin Peter Evan | Director,TenPercentOwner | M 選擇權執行 | 2.9M | – | – | 2.9M | SEC |
| 2026-02-09 | 02-12 | Kiselak Tomas | TenPercentOwner | M 選擇權執行 | 5.8M | – | – | 5.8M | SEC |
| 2026-02-09 | 02-12 | Fairmount Healthcare Co-Invest V L.P. | TenPercentOwner | M 選擇權執行 | 5.8M | – | – | 5.8M | SEC |
| 2026-02-09 | 02-12 | Bruno Julianne | Director | M 選擇權執行 | 129K | – | – | 137K | SEC |
| 2026-02-09 | 02-12 | Fairmount Healthcare Co-Invest V L.P. | TenPercentOwner | M 選擇權執行 | 2.9M | – | – | 2.9M | SEC |
| 2026-02-09 | 02-12 | Fairmount Healthcare Fund II L.P. | TenPercentOwner | M 選擇權執行 | 2.9M | – | – | 2.9M | SEC |
| 2026-02-09 | 02-12 | Fairmount Funds Management LLC | Director,TenPercentOwner | M 選擇權執行 | 2.9M | – | – | 2.9M | SEC |
| 2026-01-05 | 01-26 | Sattarzadeh Sherwin | Chief Operating Officer | A 獲配股票 | 190K | – | – | 190K | SEC |
| 2026-01-05 | 01-07 | Hewes L. Becker | Chief Medical Officer | A 獲配股票 | 265K | – | – | 265K | SEC |
| 2026-01-02 | 01-06 | Schambye Hans T. | Chief Executive Officer | S 公開市場賣出 | 700 | 21.38 | 15K | 4.7K | SEC |
| 2026-01-02 | 01-06 | Winslow Garrett | General Counsel | S 公開市場賣出 | 255 | 21.38 | 5K | 1.9K | SEC |
| 2026-01-02 | 01-06 | Schambye Hans T. | Chief Executive Officer | M 選擇權執行 | 1.4K | – | – | 5.4K | SEC |
| 2026-01-02 | 01-06 | Firmani Lori | Chief Financial Officer | S 公開市場賣出 | 135 | 21.41 | 3K | 931 | SEC |
| 2026-01-02 | 01-06 | Firmani Lori | Chief Financial Officer | M 選擇權執行 | 374 | – | – | 1.1K | SEC |
| 2026-01-02 | 01-06 | Winslow Garrett | General Counsel | M 選擇權執行 | 680 | – | – | 2.1K | SEC |
| 2025-07-03 | 07-08 | Firmani Lori | Interim CFO | S 公開市場賣出 | 147 | 3.39 | 498.33 | 692 | SEC |
| 2025-07-03 | 07-08 | Schambye Hans T. | Chief Executive Officer | S 公開市場賣出 | 735 | 3.38 | 2K | 4.0K | SEC |
| 2025-07-03 | 07-08 | Schambye Hans T. | Chief Executive Officer | M 選擇權執行 | 1.4K | – | – | 4.8K | SEC |
| 2025-07-03 | 07-08 | Firmani Lori | Interim CFO | M 選擇權執行 | 374 | – | – | 839 | SEC |
| 2025-07-03 | 07-08 | Winslow Garrett | General Counsel | S 公開市場賣出 | 260 | 3.39 | 881.40 | 1.4K | SEC |
| 2025-07-03 | 07-08 | Winslow Garrett | General Counsel | M 選擇權執行 | 680 | – | – | 1.7K | SEC |
| 2025-01-03 | 01-07 | Firmani Lori | Interim CFO | M 選擇權執行 | 726 | – | – | 726 | SEC |
| 2025-01-03 | 01-07 | Schambye Hans T. | Chief Executive Officer | S 公開市場賣出 | 1.3K | 5.60 | 8K | 3.4K | SEC |
| 2025-01-03 | 01-07 | Firmani Lori | Interim CFO | S 公開市場賣出 | 261 | 5.63 | 1K | 465 | SEC |
| 2025-01-03 | 01-07 | Winslow Garrett | General Counsel | S 公開市場賣出 | 471 | 5.60 | 3K | 1.0K | SEC |
| 2025-01-03 | 01-07 | Schambye Hans T. | Chief Executive Officer | M 選擇權執行 | 2.6K | – | – | 4.7K | SEC |
| 2025-01-03 | 01-07 | Winslow Garrett | General Counsel | M 選擇權執行 | 1.3K | – | – | 1.5K | SEC |
| 2023-08-15 | 08-17 | ORBIMED ADVISORS LLC | TenPercentOwner | S 公開市場賣出 | 38.3K | 0.75 | 29K | 97.2K | SEC |
| 2023-08-15 | 08-17 | OrbiMed Genesis GP LLC | TenPercentOwner | S 公開市場賣出 | 536K | 0.75 | 402K | 1.5M | SEC |
| 2023-08-15 | 08-17 | OrbiMed Genesis GP LLC | TenPercentOwner | S 公開市場賣出 | 249K | 0.75 | 187K | 631K | SEC |
| 2023-08-15 | 08-17 | OrbiMed Capital GP VII LLC | TenPercentOwner | S 公開市場賣出 | 536K | 0.75 | 402K | 1.5M | SEC |
| 2023-08-15 | 08-17 | OrbiMed Capital GP VII LLC | TenPercentOwner | S 公開市場賣出 | 249K | 0.75 | 187K | 631K | SEC |
| 2023-08-15 | 08-17 | OrbiMed Capital GP VII LLC | TenPercentOwner | S 公開市場賣出 | 38.3K | 0.75 | 29K | 97.2K | SEC |
| 2023-08-15 | 08-17 | OrbiMed Advisors Israel II Ltd | TenPercentOwner | S 公開市場賣出 | 536K | 0.75 | 402K | 1.5M | SEC |
| 2023-08-15 | 08-17 | OrbiMed Advisors Israel II Ltd | TenPercentOwner | S 公開市場賣出 | 249K | 0.75 | 187K | 631K | SEC |
| 2023-08-15 | 08-17 | OrbiMed Advisors Israel II Ltd | TenPercentOwner | S 公開市場賣出 | 38.3K | 0.75 | 29K | 97.2K | SEC |
| 2023-08-15 | 08-17 | OrbiMed Israel GP II, L.P. | TenPercentOwner | S 公開市場賣出 | 536K | 0.75 | 402K | 1.5M | SEC |
| 2023-08-15 | 08-17 | OrbiMed Israel GP II, L.P. | TenPercentOwner | S 公開市場賣出 | 38.3K | 0.75 | 29K | 97.2K | SEC |
| 2023-08-15 | 08-17 | OrbiMed Genesis GP LLC | TenPercentOwner | S 公開市場賣出 | 38.3K | 0.75 | 29K | 97.2K | SEC |
| 2023-08-15 | 08-17 | OrbiMed Israel GP II, L.P. | TenPercentOwner | S 公開市場賣出 | 249K | 0.75 | 187K | 631K | SEC |
| 2023-08-15 | 08-17 | ORBIMED ADVISORS LLC | TenPercentOwner | S 公開市場賣出 | 536K | 0.75 | 402K | 1.5M | SEC |
| 2023-08-15 | 08-17 | ORBIMED ADVISORS LLC | TenPercentOwner | S 公開市場賣出 | 249K | 0.75 | 187K | 631K | SEC |
| 2023-07-31 | 08-02 | OrbiMed Genesis GP LLC | TenPercentOwner | S 公開市場賣出 | 26.6K | 3.00 | 80K | 136K | SEC |
| 2023-07-31 | 08-02 | OrbiMed Capital GP VII LLC | TenPercentOwner | S 公開市場賣出 | 153K | 3.00 | 459K | 2.1M | SEC |
| 2023-07-31 | 08-02 | OrbiMed Capital GP VII LLC | TenPercentOwner | S 公開市場賣出 | 29.7K | 3.00 | 89K | 880K | SEC |
| 2023-07-31 | 08-02 | OrbiMed Advisors Israel II Ltd | TenPercentOwner | S 公開市場賣出 | 153K | 3.00 | 459K | 2.1M | SEC |
| 2023-07-31 | 08-02 | OrbiMed Advisors Israel II Ltd | TenPercentOwner | S 公開市場賣出 | 29.7K | 3.00 | 89K | 880K | SEC |
| 2023-07-31 | 08-02 | OrbiMed Advisors Israel II Ltd | TenPercentOwner | S 公開市場賣出 | 26.6K | 3.00 | 80K | 136K | SEC |
| 2023-07-31 | 08-02 | OrbiMed Israel GP II, L.P. | TenPercentOwner | S 公開市場賣出 | 153K | 3.00 | 459K | 2.1M | SEC |
| 2023-07-31 | 08-02 | OrbiMed Israel GP II, L.P. | TenPercentOwner | S 公開市場賣出 | 29.7K | 3.00 | 89K | 880K | SEC |
| 2023-07-31 | 08-02 | OrbiMed Capital GP VII LLC | TenPercentOwner | S 公開市場賣出 | 26.6K | 3.00 | 80K | 136K | SEC |
| 2023-07-31 | 08-02 | OrbiMed Israel GP II, L.P. | TenPercentOwner | S 公開市場賣出 | 26.6K | 3.00 | 80K | 136K | SEC |
| 2023-07-31 | 08-02 | ORBIMED ADVISORS LLC | TenPercentOwner | S 公開市場賣出 | 153K | 3.00 | 459K | 2.1M | SEC |
| 2023-07-31 | 08-02 | ORBIMED ADVISORS LLC | TenPercentOwner | S 公開市場賣出 | 29.7K | 3.00 | 89K | 880K | SEC |
| 2023-07-31 | 08-02 | OrbiMed Genesis GP LLC | TenPercentOwner | S 公開市場賣出 | 29.7K | 3.00 | 89K | 880K | SEC |
| 2023-07-31 | 08-02 | ORBIMED ADVISORS LLC | TenPercentOwner | S 公開市場賣出 | 26.6K | 3.00 | 80K | 136K | SEC |
| 2023-07-31 | 08-02 | OrbiMed Genesis GP LLC | TenPercentOwner | S 公開市場賣出 | 153K | 3.00 | 459K | 2.1M | SEC |
| 2023-07-25 | 07-27 | ORBIMED ADVISORS LLC | TenPercentOwner | S 公開市場賣出 | 4.7K | 2.92 | 14K | 910K | SEC |
| 2023-07-25 | 07-27 | OrbiMed Genesis GP LLC | TenPercentOwner | S 公開市場賣出 | 4.7K | 2.92 | 14K | 910K | SEC |
| 2023-07-25 | 07-27 | OrbiMed Genesis GP LLC | TenPercentOwner | S 公開市場賣出 | 7.8K | 2.92 | 23K | 162K | SEC |
| 2023-07-25 | 07-27 | OrbiMed Capital GP VII LLC | TenPercentOwner | S 公開市場賣出 | 26.7K | 2.92 | 78K | 2.3M | SEC |
| 2023-07-25 | 07-27 | OrbiMed Capital GP VII LLC | TenPercentOwner | S 公開市場賣出 | 7.8K | 2.92 | 23K | 162K | SEC |
| 2023-07-25 | 07-27 | OrbiMed Advisors Israel II Ltd | TenPercentOwner | S 公開市場賣出 | 26.7K | 2.92 | 78K | 2.3M | SEC |
| 2023-07-25 | 07-27 | OrbiMed Advisors Israel II Ltd | TenPercentOwner | S 公開市場賣出 | 4.7K | 2.92 | 14K | 910K | SEC |
| 2023-07-25 | 07-27 | OrbiMed Advisors Israel II Ltd | TenPercentOwner | S 公開市場賣出 | 7.8K | 2.92 | 23K | 162K | SEC |
| 2023-07-25 | 07-27 | OrbiMed Israel GP II, L.P. | TenPercentOwner | S 公開市場賣出 | 26.7K | 2.92 | 78K | 2.3M | SEC |
| 2023-07-25 | 07-27 | OrbiMed Capital GP VII LLC | TenPercentOwner | S 公開市場賣出 | 4.7K | 2.92 | 14K | 910K | SEC |
| 2023-07-25 | 07-27 | OrbiMed Israel GP II, L.P. | TenPercentOwner | S 公開市場賣出 | 4.7K | 2.92 | 14K | 910K | SEC |
| 2023-07-25 | 07-27 | OrbiMed Israel GP II, L.P. | TenPercentOwner | S 公開市場賣出 | 7.8K | 2.92 | 23K | 162K | SEC |
| 2023-07-25 | 07-27 | ORBIMED ADVISORS LLC | TenPercentOwner | S 公開市場賣出 | 26.7K | 2.92 | 78K | 2.3M | SEC |
| 2023-07-25 | 07-27 | OrbiMed Genesis GP LLC | TenPercentOwner | S 公開市場賣出 | 26.7K | 2.92 | 78K | 2.3M | SEC |
| 2023-07-25 | 07-27 | ORBIMED ADVISORS LLC | TenPercentOwner | S 公開市場賣出 | 7.8K | 2.92 | 23K | 162K | SEC |
| 2023-07-13 | 07-17 | ORBIMED ADVISORS LLC | TenPercentOwner | S 公開市場賣出 | 9.8K | 2.40 | 24K | 170K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ | 48.7K | 1K | 新進 | 新進 |
| HARBOUR INVESTMENTS, INC. | 40 | 1K | 新進 | 新進 |
| ROTHSCHILD INVESTMENT LLC | 34 | 884.00 | 新進 | 新進 |
持有機構數近 12 季
| 持有機構 · 季變化 | 3 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 3 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 48.8K · 0.1% |
| 合計季末市值 | 3K |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 4.1M |
|---|---|
| 與上期比 | -12.8% |
| 佔流通股數 | 6.69% |
| 日均成交量 | 311K |
| 回補天數 | 13.3 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 4.1M | -12.8% | 6.69% | 311K | 13.3 |
| 2026-08-14 | 4.7M | -3.1% | 7.68% | 349K | 13.6 |
| 2026-07-31 | 4.9M | +4.4% | 7.93% | 418K | 11.7 |
| 2026-07-15 | 4.7M | +31.4% | 7.59% | 580K | 8.1 |
| 2026-06-30 | 3.6M | +172.3% | 5.78% | 1.4M | 2.6 |
| 2026-06-15 | 1.3M | -6.6% | 2.12% | 389K | 3.4 |
| 2026-05-29 | 1.4M | +8.7% | 2.27% | 339K | 4.1 |
| 2026-05-15 | 1.3M | +8.4% | 2.09% | 418K | 3.1 |
| 2026-04-30 | 1.2M | +6.7% | 1.93% | 216K | 5.5 |
| 2026-04-15 | 1.1M | +35.0% | 1.81% | 236K | 4.7 |
| 2026-03-31 | 827K | +93.4% | 1.34% | 336K | 2.5 |
| 2026-03-13 | 428K | +31.6% | 0.69% | 221K | 1.9 |